Diseases & Disorders
(G115)
990 on File
CHARLES L SHOR FOUNDATION FOR EPILEPSY RESEARCH INC
Financial strength (30%)
71/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$1.2M
Total Revenue
$2.7M
Total Expenses
$26.5M
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
96.5%
Fundraising Efficiency
N/A
Operating Reserve
118.65x
Liability-to-Asset
2.4%
Revenue Diversification
92.4%
Executive Compensation
$223K
Compared with Peers
FY 2024
Compared with 638 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
96.5% | 82.3% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
118.7 mo | 11.4 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.4% | 12.7% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
92.4% | 91.5% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
59.2% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-8.9% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-119.3% | 2.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $1.2M | $2.7M | $26.5M | 96.5% | — |
| 2023 | $767K | $2.9M | $28.0M | 99.0% | — |
| 2022 | $1.7M | $2.4M | $30.0M | 98.5% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.